153 related articles for article (PubMed ID: 8636759)
1. Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
Feugeas O; Guriec N; Babin-Boilletot A; Marcellin L; Simon P; Babin S; Thyss A; Hofman P; Terrier P; Kalifa C; Brunat-Mentigny M; Patricot LM; Oberling F
J Clin Oncol; 1996 Feb; 14(2):467-72. PubMed ID: 8636759
[TBL] [Abstract][Full Text] [Related]
2. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
[TBL] [Abstract][Full Text] [Related]
3. Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma.
Heinsohn S; Evermann U; Zur Stadt U; Bielack S; Kabisch H
Int J Oncol; 2007 May; 30(5):1205-14. PubMed ID: 17390023
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas.
Belchis DA; Meece CA; Benko FA; Rogan PK; Williams RA; Gocke CD
Diagn Mol Pathol; 1996 Sep; 5(3):214-9. PubMed ID: 8866236
[TBL] [Abstract][Full Text] [Related]
5. Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas.
Goto A; Kanda H; Ishikawa Y; Matsumoto S; Kawaguchi N; Machinami R; Kato Y; Kitagawa T
Jpn J Cancer Res; 1998 May; 89(5):539-47. PubMed ID: 9685858
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
7. [Detection of RB gene in osteosarcoma by PCR].
Li HG
Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):714-6. PubMed ID: 8033699
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity for Rb locus and pRb immunostaining in laryngeal cancer: a clinicopathologic, molecular and immunohistochemical study.
Pietruszewska W; Klatka J; Borzecki A; Rieske P
Folia Histochem Cytobiol; 2008; 46(4):479-85. PubMed ID: 19141402
[TBL] [Abstract][Full Text] [Related]
10. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors.
Woloschak M; Roberts JL; Post KD
Cancer; 1994 Jul; 74(2):693-6. PubMed ID: 8033049
[TBL] [Abstract][Full Text] [Related]
12. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors associated with loss of heterozygosity at the RB1 locus in retinoblastoma.
Munier FL; Thonney F; Balmer A; Uffer S; Héon E; Van Melle G; Rutz HP; Pescia G; Schorderet DF
Ophthalmic Genet; 1997 Mar; 18(1):7-12. PubMed ID: 9134545
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.
Cho JH; Noguchi M; Ochiai A; Hirohashi S
Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493
[TBL] [Abstract][Full Text] [Related]
18. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.
Toguchida J; Ishizaki K; Sasaki MS; Ikenaga M; Sugimoto M; Kotoura Y; Yamamuro T
Cancer Res; 1988 Jul; 48(14):3939-43. PubMed ID: 2898286
[TBL] [Abstract][Full Text] [Related]
20. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
